Clinical factors associated with outcome in metastatic renal cell carcinoma patients treated with VEGF-targeted therapy

被引：0
|
作者：
Golshayan, A. [1 ]
Choueiri, T. K. [1 ]
Elson, P. [1 ]
Garcia, J. A. [1 ]
Khaswneh, M. [1 ]
Usman, S. [1 ]
Tamaskar, I. [1 ]
Wood, L. [1 ]
Rini, B. I. [1 ]
Bukowski, R. M. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5046
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC)
    C Seidel
    J Busch
    S Weikert
    S Steffens
    C Bokemeyer
    V Grünwald
    British Journal of Cancer, 2013, 109 : 2998 - 3004
  • [42] Brain metastases in patients treated with targeted therapy for metastatic renal cell carcinoma (mRCC)
    Alharbi, H.
    Choueiri, T. K.
    Kollmannsberger, C. K.
    North, S.
    MacKenzie, M. J.
    Knox, J. J.
    Rini, B. I.
    Heng, D. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [43] Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma
    You, Dalsan
    Lee, Chunwoo
    Jeong, In Gab
    Song, Cheryn
    Lee, Jae-Lyun
    Hong, Bumsik
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (11) : 2331 - 2338
  • [44] Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma
    Dalsan You
    Chunwoo Lee
    In Gab Jeong
    Cheryn Song
    Jae-Lyun Lee
    Bumsik Hong
    Jun Hyuk Hong
    Hanjong Ahn
    Choung-Soo Kim
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 2331 - 2338
  • [45] Correlative analyses of serum biomarkers and clinical outcomes in the phase 2 study of lenvatinib, everolimus, and the combination, in patients with metastatic renal cell carcinoma following 1 VEGF-targeted therapy
    Glen, H.
    Hsieh, J.
    Michaelson, M. D.
    Kim, H. J.
    Sachdev, P.
    Kadowaki, T.
    Funahashi, Y.
    Larkin, J.
    Motzer, R.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S89 - S89
  • [46] Utilizing pre-therapy clinical schema and initial CT changes to predict progression-free survival in patients with metastatic renal cell carcinoma on VEGF-targeted therapy: A preliminary analysis
    Smith, Andrew D.
    Shah, Shetal N.
    Rini, Brian I.
    Lieber, Michael L.
    Remer, Erick M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (07) : 1283 - 1291
  • [47] Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC)
    Seidel, C.
    Busch, J.
    Weikert, S.
    Steffens, S.
    Bokemeyer, C.
    Gruenwald, V.
    BRITISH JOURNAL OF CANCER, 2013, 109 (12) : 2998 - 3004
  • [48] Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma
    De Velasco, Guillermo
    Xie, Wanling
    Donskov, Frede
    Albiges, Laurence
    Beuselinck, Benoit
    Srinivas, Sandy
    Agarwal, Neeraj
    Lee, Jae Lyun
    Brugarolas, James
    Wood, Lori A.
    Rha, Sun-young
    Kollmannsberger, Christian
    North, Scott
    Kanesvaran, Ravindran
    Rini, Brian I.
    Broom, Reuben
    Yamamoto, Haru
    Kaymakcalan, Marina D.
    Heng, Daniel Y. C.
    Choueiri, Toni K.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : 403 - 410
  • [49] The effect of activation of angiogenesis pathways independent of VEGF in renal cell carcinoma on resistance to VEGF-targeted antiangiogenic therapy.
    Han, Kyung Seok
    Gust, Kilian
    Awrey, Shannon
    Raven, Peter A.
    Li, Estelle
    Fazli, Ladan
    Gleave, Martin E.
    So, Alan I.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [50] Association of percentage of tumor burden removed with debulking nephrectomy and progression-free survival (PFS) in metastatic renal cell carcinoma (mRCC) patients (Pts) treated with VEGF-targeted therapy
    Barbastefano, J.
    Garcia, J. A.
    Elson, P.
    Wood, L. S.
    Lane, B. S.
    Dreicer, R.
    Campbell, S.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345